Charles River Laboratories International, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Charles River Laboratories International, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4466
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:63
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Charles River Laboratories International, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Charles River Laboratories International, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Charles River Laboratories International, Inc. (CRL or ‘the company’) is a full service, early-stage contract research organization. Its core competencies and research model technologies allows it to develop a range of discovery and safety assessment services in both GLP and non-GLP standards. In addition, it provides various services related to clients manufacturing activities. These include basic research services (research animal models, surgical services, genetic testing services, colony management services, health monitoring services), drug discovery and safety assessment services, clinical support services, operations and staffing support services, and manufacturing support services (endotoxin and microbial detection, biologics testing solutions, and avian vaccine services). The company operates in the US, Europe, Japan, Canada and other regions of the world. CRL is headquartered in Wilmington, Massachusetts, the US.

Scope

- Detailed information on Charles River Laboratories International, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Charles River Laboratories International, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Charles River Laboratories International, Inc. including a breakdown and examination of key business segments
- Intelligence on Charles River Laboratories International, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Charles River Laboratories International, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Charles River Laboratories International, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Charles River Laboratories International, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Charles River Laboratories International, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Charles River Laboratories International, Inc.: Company Overview 9
Charles River Laboratories International, Inc.: Overview and Key Facts 9
Charles River Laboratories International, Inc.: Overview 9
Charles River Laboratories International, Inc.: Key Facts 9
Charles River Laboratories International, Inc.: Key Employees 11
Charles River Laboratories International, Inc.: Key Employee Biographies 13
Charles River Laboratories International, Inc.: Major Products and Services 20
Charles River Laboratories International, Inc.: Company History 21
Charles River Laboratories International, Inc.: Management Statement 26
Charles River Laboratories International, Inc.: Locations and Subsidiaries 30
Charles River Laboratories International, Inc.: Key Competitors 31
Charles River Laboratories International, Inc.: Company Analysis 32
Charles River Laboratories International, Inc.: Business Description 32
Charles River Laboratories International, Inc.: SWOT Analysis 34
Charles River Laboratories International, Inc.: SWOT Overview 34
Charles River Laboratories International, Inc.: Strengths 34
Charles River Laboratories International, Inc.: Weaknesses 35
Charles River Laboratories International, Inc.: Opportunities 35
Charles River Laboratories International, Inc.: Threats 38
Charles River Laboratories International, Inc.: Corporate Financial Deals Activity 40
Charles River Laboratories International, Inc.: Financial Deals Overview 40
Charles River Laboratories International, Inc.: Targets and Partners 42
Charles River Laboratories International, Inc.: Top Deals 2014 – 2018YTD* 44
Charles River Laboratories International, Inc.: Advisors 45
Charles River Laboratories International, Inc.: Top Legal Advisors 45
Charles River Laboratories International, Inc.: Top Financial Advisors 45
Charles River Laboratories International, Inc.: Mergers and Acquisitions 46
Charles River Laboratories International, Inc.: Corporate Venturing 47
Charles River Laboratories International, Inc.: Capital Raising 48
Charles River Laboratories International, Inc.: Partnership 49
Charles River Laboratories International, Inc.: Divestments 50
Charles River Laboratories International, Inc.: Recent Developments 51
Charles River Laboratories International, Inc.: News and Events Summary 51
Charles River Laboratories International, Inc.: Business Expansion 56
Charles River Laboratories International, Inc.: Contracts 57
Charles River Laboratories International, Inc.: Corporate Governance 58
Charles River Laboratories International, Inc.: Financial Performance 58
Charles River Laboratories International, Inc.: Market Developments 58
Charles River Laboratories International, Inc.: Strategy and Operations 60
Appendix 61
Contact Us 61
Methodology 61
About MarketLine 62

List of Tables
Table 1: Charles River Laboratories International, Inc.: Key Facts
Table 2: Charles River Laboratories International, Inc.: Key Employees
Table 3: Charles River Laboratories International, Inc.: Locations and Subsidiaries
Table 4: Charles River Laboratories International, Inc.: Key Competitors
Table 5: Charles River Laboratories International, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Charles River Laboratories International, Inc.: M&A Activity by Geography (TTM*)
Table 7: Charles River Laboratories International, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Charles River Laboratories International, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Charles River Laboratories International, Inc.: Targets and Partners
Table 10: Charles River Laboratories International, Inc.: Top Deals 2014 - 2018YTD*
Table 11: Charles River Laboratories International, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Charles River Laboratories International, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Charles River Laboratories International, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Charles River Laboratories International, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Charles River Laboratories International, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 16: Charles River Laboratories International, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 17: Charles River Laboratories International, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 18: Charles River Laboratories International, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 19: Charles River Laboratories International, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 20: Charles River Laboratories International, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 21: Charles River Laboratories International, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 22: Charles River Laboratories International, Inc.: News and Events Summary
Table 23: Charles River Laboratories International, Inc.: Business Expansion
Table 24: Charles River Laboratories International, Inc.: Contracts
Table 25: Charles River Laboratories International, Inc.: Corporate Governance
Table 26: Charles River Laboratories International, Inc.: Financial Performance
Table 27: Charles River Laboratories International, Inc.: Market Developments
Table 28: Charles River Laboratories International, Inc.: Strategy and Operations

List of Figures
Figure 1: Charles River Laboratories International, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Charles River Laboratories International, Inc.: M&A Activity by Geography (TTM*)
Figure 3: Charles River Laboratories International, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Charles River Laboratories International, Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Charles River Laboratories International, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Charles River Laboratories International, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Charles River Laboratories International, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Charles River Laboratories International, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Charles River Laboratories International, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 10: Charles River Laboratories International, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 11: Charles River Laboratories International, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 12: Charles River Laboratories International, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 13: Charles River Laboratories International, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Charles River Laboratories International, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dayton Superior Corp:企業の戦略的SWOT分析
    Dayton Superior Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • AnGes Inc (4563):製薬・医療:M&Aディール及び事業提携情報
    Summary AnGes Inc (AnGes) is a biopharmaceutical company which discovers and develops gene and nucleotide based drugs and reagents for use in functional analysis of genetic medication. The company specializes in research and development (R&D) and practical application of genetic medicine. It has two …
  • Mitsui Chemicals, Inc.:企業の戦略・SWOT・財務分析
    Mitsui Chemicals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mitsui Chemicals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Braeburn Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Braeburn Pharmaceuticals Inc (Braeburn), a subsidiary of Apple Tree Partners is a pharmaceutical company that develops novel and long-acting implantable and injectable treatments.The company’s product pipeline includes Probuphine, CAM2038, BB-0417, BB-0817, BB-1216. Its Probuphine, is a a si …
  • Albireo Pharma Inc (ALBO):製薬・医療:M&Aディール及び事業提携情報
    Summary Albireo Pharma Inc (Albireo), formerly Biodel Inc., focuses on the development and commercialization of innovative bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal (GI) disorders and diseases where inappropriate flow of bile causes severe med …
  • Saint-Gobain Weber GmbH:企業の戦略・SWOT・財務分析
    Saint-Gobain Weber GmbH - Strategy, SWOT and Corporate Finance Report Summary Saint-Gobain Weber GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Dialog Group Bhd (DIALOG):企業の財務・戦略的SWOT分析
    Dialog Group Bhd (DIALOG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Honda Motor Co Ltd (7267):企業の財務・戦略的SWOT分析
    Honda Motor Co Ltd (7267) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Nutra Pharma Corp (NPHC):企業の財務・戦略的SWOT分析
    Nutra Pharma Corp (NPHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Facebook Inc (FB):企業の財務・戦略的SWOT分析
    Facebook Inc (FB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Wuxi Pharmatech (Cayman) Inc:企業のM&A・事業提携・投資動向
    Wuxi Pharmatech (Cayman) Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wuxi Pharmatech (Cayman) Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • SS&C Advent:企業の戦略的SWOT分析
    SS&C Advent - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Ascential plc (formerly Top Right Group Limited):企業のM&A・事業提携・投資動向
    Ascential plc (formerly Top Right Group Limited) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ascential plc (formerly Top Right Group Limited) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descri …
  • Dah Sing Bank, Limited:企業の戦略・SWOT・財務情報
    Dah Sing Bank, Limited - Strategy, SWOT and Corporate Finance Report Summary Dah Sing Bank, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Trinity Mirror plc:企業の戦略・SWOT・財務情報
    Trinity Mirror plc - Strategy, SWOT and Corporate Finance Report Summary Trinity Mirror plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Ensign Bickford Aerospace & Defense Company:企業の戦略・SWOT・財務情報
    Ensign Bickford Aerospace & Defense Company - Strategy, SWOT and Corporate Finance Report Summary Ensign Bickford Aerospace & Defense Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Genome Institute of Singapore-製薬・医療分野:企業M&A・提携分析
    Summary Genome Institute of Singapore (GIS) is a research institute that provides various research programs and services in different areas. The institute concentrates on genomic sciences to improve public health and prosperity in Singapore. It handles the latest in technology and comprises early ca …
  • Telenet Group Holding NV:企業の戦略・SWOT・財務分析
    Telenet Group Holding NV - Strategy, SWOT and Corporate Finance Report Summary Telenet Group Holding NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Credit Du Nord Sa
    Credit Du Nord Sa - Strategy, SWOT and Corporate Finance Report Summary Credit Du Nord Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • San Miguel Corp:企業の戦略・SWOT・財務情報
    San Miguel Corp - Strategy, SWOT and Corporate Finance Report Summary San Miguel Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆